742. A New Model of Autosomal Dominant Polycystic Kidney Disease: Overexpression of a Human PKD2 Transgene in Mice

   E                (C@ 0

     ''.%CA    

            

    0    

                - /       

741. Delivery of Human Tissue Kallikrein Gene Mediates Reductions in Blood Pressure and the Levels of Plasma Insulin and Blood Glucose in Fructose-Induced Hypertensive Rats with Diabetes Tao Wang,1 Chunxia Zhao,1 Peihua Wang,1 Dao Wen Wang,1 Xiao Xiao,1,2 Lee Chao.3 1 Department of Internal Medicine and Gene Therapy Center of Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China; 2Department of Molecular Genetics and Biochemistry, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States; 3Department of Biochemistry and Molecular Biology, Medical University of South Carolina, Charleston, SC, United States. )E  7                  

                       C               

                

 

               

             " 

           #   7 #  (  "$     

   "   -89H/            ! $*'=8        $*' -CA/ -8    

  /  

      " 

      -MB/   , 

               E 

     -MB/            

 

 

   & 

        

      

                        E     

    @ 7 ' 

   E   $*'"CA 

   

         =    E        

  = 

 -? 8/ '        

           -   CA"   869±=&= %D  5B6±,B= %D/    - CA" B:=±,B%D6==±8& % D O998/  



        CA" 

            

   89H      2            

 

          E   3        

       0   2            >D('    $*'" CA  

  7                      

                              " 

                          CA              

742. A New Model of Autosomal Dominant Polycystic Kidney Disease: Overexpression of a Human PKD2 Transgene in Mice Stephane J. Burtey,1 Philippe Pautre,1 Yvon Berland,2,3 Michel Fontes.1 1 U491, INSERM, Marseille, France; 2Service de Néphrologie, APHM, Marseille, France; 3Centre d′Investigation Clinique, INSERM/APHM, Marseille, France. '         -'$!A$/     

             8  :99    '$!A$     G

           

                 ->(@$/  



    '$!A$     &H  >(@$        /?.'   

:&H'$!A$ 

8B8==    6=9=        " 8 -!8/    !8    !8        -                   0/ !8             " 3   "      ,&99    3     /?.,           '$!A$  

  61,8",=      5B:               , -!,/   B    "        *C,   ))C   !,               !8   !,                 

       /?.' /?.,  '$!A$         /0'   /0, " 

              /0'           /0,  G          /0'   /0, 

 "               G 

 

        /0' "%"     /0' J%"                  ?  /0,  ′   

     /0, -/     /0, "%    

 

     -              /     '$!A$            2     3   /?.'       

        /?.'            4          !' -!8     / 

               !,                                  '$!A$   

          '$!A$          3     /?.'   !,           3   /?.,

       

 )                      0               0

          /?.,      0  E 

  2' -      /    /?.,     2'  8:&A0 

       

   

                    2'               /?.,    0  



                              3           /?.,            !        0                       0  

                     )    '$!A$    

                      

            /0, A)                 

        '$!A$

0    

                - /        Molecular Therapy Vol. 5, No. 5, May 2002, Part 2 of 2 Parts Copyright © The American Society of Gene Therapy

S243

"8 " !" !  "8 "!" !  743. Neuroprotective Effect of HSV-Mediated Gene Transfer of NGF in Cisplatin Neuropathy Munmun Chattopadhyay,1 William Goins,2 Joseph C. Glorioso,2 Marina Mata,1 David J. Fink.1,2,3 1 Neurology, University of Pittsburgh, Pittsburgh, PA, United States; 2Molecular Genetics & Biochemistry, University of Pittsburgh, Pittsburgh, PA, United States; 3GRECC, Pittsburgh VA Healthcare System, Pittsburgh, PA, United States. (               "         *        

                      

     1             0     

 

   C(."



          "=       3 " 

                3

 

    C(."



                 -*?/     " 

     #  0      ,99  ,&9    E 

    

   B 

    -= % /     

  

         

 8&             ?      



 -  8;B J%" 9; .;,J%"9B .!O9998/C"  



- ,:J%"9,.9&J%"9,.!O9998/      



- ;8J%"B . ,5 .J%"8!O9998/  

     

  

               - :,J%"95 96J%"9,!O9998/    

     -  ,6 J%" 98    &5 J%" 9=   ! O 998/ ' 

              

   ,& 3 89;     *?" 3      C(.    (C* =                   

        -8,8 J%" 96  . ! O 99& 

    '*).'/C"  -,6J%"9,.!O99& 

      '*).'/        

-B6=J%"86 .!O99&

  '*).'/                

              2         

         -, J%" 9=  ! O 99& 

      '*).'/       

     -,5 J%" 98    ! O 99& 

      '*).'/      

  (C*           C(."



     3   *?            " 

  

      C(."



                                  

744. Hematopoietic Stem Cell Gene Therapy for a Neurodegenerative Disorder Disorder,, X-Linked Adrenoleukodystrophy : Correction of Brain Microglia Sonia Benhamida,1 Françoise Pflumio,2 Muriel Asheuer,1 Marina Cavazzana-Calvo,3 Serge Fichelson,2 Anne DubartKupperschmitt,2 Pierre Charneau,4 Patrick Aubourg,1 Nathalie Cartier.1 1 INSERM U342, Hôpital Saint Vincent de Paul, Paris, France; 2 INSERM U474, Hôpital Cochin, Paris, France; 3Laboratoire de Thérapie Cellulaire, Hôpital Necker, Paris, France; 4Laboratoire d′oncologie virale, Institut Pasteur, Paris, France. F"

       -'D$/              G

                                   -.D?'/ !    'D$-;9H/

                 

    ="&     'D$       "  

    G

          3           ' !"                        ""     'D$ 

   > 

S244

2#       

 

      CD'"      

        '         -C(/                          

  C.8"'D$    - @!" >?8 "'D$/      $=6J   G

         'D$   &B";&H $=6J   3 

 'D$    

 

        'D$    'D$   

3    

    " 

      "       =9"&9H       

  3 

'D$              

 $=6J     E 

 ($"*)$   '   G

  

 

           $B:    %      3  'D$     

   "  *)$%($   



     

 'D$   $=6J       

     %      3   'D$!          G        *)$"($   

 

                   $

       @'    'D$!  

              3 

 'D$     

             

    'D$ $=6J              - / 

3  'D$!       *)$%($   '                                

      

         C." 

   

745. Inhibiting HIV in the Central Nervous System; Recombinant SV40-Derived Gene Delivery V ectors Vectors Effectively T ransduce Neurons and Protect Them from Transduce HIV Pierre Cordelier,1 Sandra A. Calarota,1 David S. Strayer.1 1 Pathology, Jefferson Medical College, Philadelphia, PA, United States. &'(                 C.             -*(/   

 

      *               

*(    

 @  (.69    - (.69/    

    1            

         "C."8         

       )   (.69    

         

            G

 "C."8   7 @ #89   "        C."8 @     α8"  -α8' / 

  (.-@ #89/   (.-' /    * ,%

$8   -(   /   

    

               ′     * ,"



     -* ,"*/                      

        * ,"* 

  

   (.-@ #89/   (.-' / *     



     3             

 C."8*D6"=C."8:5BC."8<@"(?<@"?D$6"   F:   2D C."8    

  >D('    ,6      )*) (.-@ #89/   (.-' /                      3 2  T5&H           

      (.69           " 

   

     

      88 

 "   '  

C."8,6* ,"* 

 (.-@ #89/ (.-' /   

        C."8    8,9 3  

      @ #89 !     C."8  

  (.69     

   " 

      

                -88 

 "  /  

 (.-@ #89/   (.-' /"  

        C."8  

 3 (*)+( "C."8     

 (.69      

C. * ,"*  

        C.   (.69"  

                              '    (.69      

                 C."8 

3 *(     '$(   Molecular Therapy Vol. 5, No. 5, May 2002, Part 2 of 2 Parts Copyright © The American Society of Gene Therapy